Donald A Barkauskas Selected Research

Donald A Barkauskas Research Topics

Disease

28	Neoplasms (Cancer) 05/2024 - 01/2009
19	Osteosarcoma (Osteogenic Sarcoma) 09/2023 - 07/2012
6	Ewing Sarcoma (Sarcoma, Ewing) 12/2022 - 11/2011
3	Rhabdomyosarcoma 01/2023 - 09/2013
3	Sarcoma (Soft Tissue Sarcoma) 12/2022 - 01/2017
3	Leukemia 01/2020 - 05/2012
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2023 - 01/2021
2	Neoplasm Metastasis (Metastasis) 07/2023 - 01/2023
2	Infections 06/2023 - 01/2020
2	Agammaglobulinemia (Hypogammaglobulinemia) 06/2023 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2023 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 04/2014
2	Cardiotoxicity 01/2019 - 07/2012
2	Stomach Neoplasms (Stomach Cancer) 03/2015 - 02/2014
2	Duodenal Ulcer (Curling's Ulcer) 03/2015 - 02/2014
1	Rupture 04/2024
1	Margins of Excision 04/2024
1	Residual Neoplasm 04/2024
1	Cytokine Release Syndrome 01/2024
1	Poliomyelitis (Polio) 06/2023
1	Lymphopenia (Lymphocytopenia) 06/2023
1	Sepsis (Septicemia) 06/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Lymphoma (Lymphomas) 11/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Hyperglycemia 12/2020
1	Nausea 12/2020
1	Wilms Tumor (Wilm's Tumor) 12/2020
1	Neuroblastoma 12/2020
1	Pleuropulmonary blastoma 12/2020
1	Fistula 12/2020
1	Synovial Sarcoma (Synovioma) 12/2020
1	Neurofibrosarcoma (MPNST) 12/2020
1	Vomiting 12/2020
1	Febrile Neutropenia 01/2020
1	Second Primary Neoplasms (Neoplasms, Second) 01/2020
1	Left Ventricular Dysfunction 01/2019
1	Heart Failure 01/2019
1	Inflammation (Inflammations) 01/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2013
6	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2016
4	Insulin (Novolin)FDA Link 01/2021 - 11/2011
3	Rituximab (Mabthera)FDA Link 06/2023 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 07/2012
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2011
2	Cell Surface ReceptorsIBA 07/2023 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 01/2021
2	AnthracyclinesIBA 01/2019 - 07/2012
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2019 - 07/2012
2	EnzymesIBA 12/2017 - 03/2015
2	MicroRNAs (MicroRNA)IBA 11/2017 - 07/2015
2	human ERBB2 proteinIBA 09/2014 - 07/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 04/2014 - 11/2011
2	Insulin-Like Growth Factor Binding Protein 3IBA 04/2014 - 11/2011
2	Polysaccharides (Glycans)IBA 02/2014 - 01/2009
1	CrizotinibIBA 10/2023
1	Azacitidine (5 Azacytidine)FDA Link 07/2023
1	fas Receptor (CD95 Antigen)IBA 07/2023
1	Fas Ligand Protein (Fas Ligand)IBA 07/2023
1	VaccinesIBA 06/2023
1	Circulating Tumor DNAIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	Etoposide (VP 16)FDA LinkGeneric 11/2021
1	Prednisone (Sone)FDA LinkGeneric 11/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2021
1	Insulin ReceptorIBA 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	lorvotuzumab mertansineIBA 12/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	Alanine Transaminase (SGPT)IBA 12/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020
1	Thymidylate SynthaseIBA 01/2020
1	TubulinIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	GuanineIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	mesoglycanIBA 01/2020
1	MethyltransferasesIBA 01/2020
1	taxaneIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	MLN 8237IBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Interleukin-33IBA 01/2018
1	ImmunosorbentsIBA 12/2017
1	LigandsIBA 12/2017

Therapy/Procedure

15	Therapeutics 01/2024 - 07/2012
10	Drug Therapy (Chemotherapy) 04/2024 - 07/2012
5	Immunotherapy 01/2021 - 08/2017
3	Radiotherapy 04/2024 - 11/2021
2	Neoadjuvant Therapy 05/2024 - 04/2024